0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Month in Archives of Dermatology |

This Month in Archives of Dermatology FREE

Arch Dermatol. 2012;148(1):15. doi:10.1001/archdermatol.2011.509.
Text Size: A A A
Published online

TRENDS IN PEDIATRIC PSORIASIS OUTPATIENT HEALTH CARE DELIVERY IN THE UNITED STATES

Most pediatric patients with psoriasis present with mild, localized disease that is primarily treated with topical medications. Management of pediatric psoriasis can be challenging owing to a lack of data and standardized treatment guidelines. In this retrospective, cross-sectional investigation, Vogel et al confirm that pediatric psoriasis visits are frequent and that dermatologists and pediatricians are the primary physicians consulted. Treatment techniques differed by patient age and physician specialty, and although the data may be biased toward milder disease, the results suggest that pediatric patients may be undertreated.

See Article

CANCER RISK IN PATIENTS WITH CHRONIC URTICARIA

Chronic urticaria is a common and frustrating disorder. More than 50% of patients continue to experience chronic urticaria 10 years after initial diagnosis. Only limited epidemiologic information is available about the exact extent of the association between chronic urticaria and cancer. In this retrospective population-based cohort study, Chen et al demonstrate that patients with chronic urticaria were at increased risk of cancer, particularly hematologic malignancies. Most cancer cases were detected within the first year of urticaria diagnosis.

See Article

HIGH FREQUENCY OF GENITAL LICHEN SCLEROSUS IN A PROSPECTIVE SERIES OF 76 PATIENTS WITH MORPHEA

Morphea and lichen sclerosus (LS) are each characterized by plaques of indurated, sclerotic, and dyschromic skin and by an inflammatory dermal infiltrate and fibrosis. Despite the similarities between the 2 entities, their exact relationship remains unclear. In this prospective multicenter study, Lutz et al demonstrate that genital LS is significantly more common in patients with morphea. Early diagnosis and treatment of genital LS with topical corticosteroids can reduce the risk of squamous cell carcinoma. These data indicate that careful examination of genital mucosa should be performed in patients with morphea to allow for early diagnosis and treatment of LS.

 Image not available.

See Article

COMPARABLE EFFECTIVENESS OF ENDOVENOUS LASER ABLATION AND HIGH LIGATION WITH STRIPPING OF THE GREAT SAPHENOUS VEIN

Chronic venous insufficiency caused by varicose veins has prevalence rates as high as 28% to 35% among adults. Treatments aim to eliminate pathologic refluxes, and high ligation and saphenous vein stripping remains the standard therapy despite recurrence rates of 30% to 40% at 5 years. Particularly at the saphenofemoral junction, recurrence is often caused by neovascularization, which might be treated with minimally invasive endovenous laser treatment (EVLT). In this randomized controlled trial, Rass et al demonstrate that both methods were equally effective and safe approaches to treating great saphenous vein incompetence, with minor advantages for EVLT with respect to cosmetic outcome and recovery.

See Article

CONSENSUS GUIDELINES FOR THE MANAGEMENT OF PLAQUE PSORIASIS

Newly approved medical therapies and laser therapies have influenced the practice patterns for the management of plaque-type psoriasis in the United States. Newly updated consensus guidelines are presented here to reflect these new agents and technologies. Management of psoriasis in special populations is discussed, including sections on children, pregnant patients, nursing mothers, elderly patients, patients with hepatitis B or C virus infections, patients with human immunodeficiency virus, and patients with malignant neoplasms. Tumor necrosis factor blockers, elective surgery, and vaccinations are also addressed.

See Article

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

501 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs